Houston, TX, April 8, 2011 – OrthoAccel® Technologies, Inc. announced this week that it received an award for the 14th Annual Medical Design Excellence Award, a premier awards program for the medical technology community, for the AcceleDent™ System. The AcceleDent™ System, which is an acceleration device to enhance orthodontics, will be recognized at the MDEA Winners Ceremony on June 8th, during the Medical Design & Manufacturing (MD&M) East 2011 Conference and Exposition in New York City, where Gold and Silver awards will be announced.
Winners are being showcased in the April 2011 issue of MD+DI magazine. Past winners included Philips Healthcare Alice PDx and Medtronic Hydrodebrider System.
The AcceleDent™ System is currently being sold to orthodontic specialists in the United Kingdom, Luxemburg, Italy, Spain, France, Hungary, and Australia. This game-changing device safely reduces treatment time for wearing braces and works as a compliment to all existing orthodontic technologies – both brackets and clear aligners. The lightweight device is intended for 20 minutes of daily use. Patients simply bite down on the Mouthpiece to hold it in place, which allows freedom of the hands to engage in other routine, daily activities during the treatment session. Patients have reported using the device while engaged in a variety of activities, including doing homework and listening to music.
In addition to the Mouthpiece, which connects to an Activator to deliver a light, pulsing force, the AcceleDent™ System includes a Travel Shell for convenience, and a Charging Port to recharge the device battery and provide compliance usage information that is captured by a microprocessor in the Activator.
Mike Lowe, CEO of OrthoAccel® commented, “We are honored to be recognized as one of the ‘groundbreaking innovations that is changing the face of healthcare.’ Significant credit goes to Bryce Rutter and team at Metaphase Design Group, our partners in creating AcceleDent™.”
The Medical Design Excellence Award products are based on the following criteria: innovative use of materials, components, or processes in the fabrication of the product, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.
OrthoAccel® has completed another pivotal US clinical trial with exciting results. FDA clearance was filed for earlier this year.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent™ System
AcceleDent™ represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent™ is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.AcceleDent.com and www.AcceleDent.co.uk or requested via email@example.com
Media Contact Michael K. Lowe, CEO +1 (832) 631-1659